These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 39328314)
1. Antifungal activity of indolicidin-derived peptide In-58 against Li S; Tang Z; Liu Z; Lv S; Yao C; Wang S; Li F Front Med (Lausanne); 2024; 11():1458951. PubMed ID: 39328314 [TBL] [Abstract][Full Text] [Related]
2. Low toxicity contributes to Sporothrix globosa invade the skin of patients in low-epidemic areas of China. Qu Y; Feng Y; Bian S; Yang Y; Li D; Liu W; Shi D Mycoses; 2024 Apr; 67(4):e13724. PubMed ID: 38584320 [TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases. Song Y; Li S; Shi Y; Zhao L; Cui Y; Yao L; Zhen Y; Chen R; Cui Y Braz J Microbiol; 2021 Mar; 52(1):81-90. PubMed ID: 32557246 [TBL] [Abstract][Full Text] [Related]
4. Antifungal Activity of a Neodymium-Doped Yttrium Aluminum Garnet 1,064-Nanometer Laser against Sporothrix globosa by Inducing Apoptosis and Pyroptosis via the NLRP3/Caspase-1 Signaling Pathway: Yan T; Li F; Li J; Chen F Microbiol Spectr; 2021 Dec; 9(3):e0136421. PubMed ID: 34908455 [TBL] [Abstract][Full Text] [Related]
5. Antifungal Activity of ToAP2D Peptide Against Yan T; Li F; Li J; Chen F Front Bioeng Biotechnol; 2021; 9():761518. PubMed ID: 34746111 [TBL] [Abstract][Full Text] [Related]
7. Borba-Santos LP; Barreto TL; Vila T; Chi KD; Dos Santos Monti F; de Farias MR; Alviano DS; Alviano CS; Futuro DO; Ferreira V; de Souza W; Ishida K; Rozental S Antimicrob Agents Chemother; 2021 Aug; 65(9):e0069921. PubMed ID: 34152816 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India. Rudramurthy SM; Shankarnarayan SA; Hemashetter BM; Verma S; Chauhan S; Nath R; Savio J; Capoor M; Kaur H; Ghosh AK; Chakrabarti A Braz J Microbiol; 2021 Mar; 52(1):91-100. PubMed ID: 32734470 [TBL] [Abstract][Full Text] [Related]
9. Morphological and physiological comparison of taxa comprising the Sporothrix schenckii complex. Zhao MD; Zhou X; Liu TT; Yang ZB J Zhejiang Univ Sci B; 2015 Nov; 16(11):940-7. PubMed ID: 26537212 [TBL] [Abstract][Full Text] [Related]
10. Studies in Phylogeny, Development of Rapid IdentificationMethods, Antifungal Susceptibility, and Growth Rates of Clinical Strains of Sporothrix schenckii Complex in Japan. Suzuki R; Yikelamu A; Tanaka R; Igawa K; Yokozeki H; Yaguchi T Med Mycol J; 2016; 57(3):E47-57. PubMed ID: 27581775 [TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid-mediated photodynamic therapy has effective antifungal activity against Sporothrix globosa in vitro. Chen R; Song Y; Zhen Y; Yao L; Shi Y; Cui Y; Li S Mycoses; 2020 Dec; 63(12):1311-1320. PubMed ID: 32816371 [TBL] [Abstract][Full Text] [Related]
12. Anti-Sporothrix activity of ibuprofen combined with antifungal. Borba-Santos LP; Nucci M; Ferreira-Pereira A; Rozental S Braz J Microbiol; 2021 Mar; 52(1):101-106. PubMed ID: 32617835 [TBL] [Abstract][Full Text] [Related]
13. Diphenyl diselenide alone and in combination with itraconazole against Sporothrix schenckii s.str. and Sporothrix globosa. Poester VR; Munhoz LS; Nogueira CW; Zeni GR; Stevens DA; Xavier MO Braz J Microbiol; 2021 Sep; 52(3):1271-1274. PubMed ID: 33909253 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and antifungal susceptibility of Sporothrix species in Jiangxi, central China. Li J; Zhan P; Jiang Q; Gao Y; Jin Y; Zhang L; Luo Y; Fan X; Sun J; de Hoog S Med Mycol; 2019 Nov; 57(8):954-961. PubMed ID: 30657948 [TBL] [Abstract][Full Text] [Related]
15. Recombinant phage displaying ToAP2D peptide with antifungal activity against Yan T; An L; Chen F Front Pharmacol; 2022; 13():1022651. PubMed ID: 36278206 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp. strains with distinct genetic and antifungal susceptibility backgrounds. Ramos MLM; Almeida-Silva F; de Souza Rabello VB; Nahal J; Figueiredo-Carvalho MHG; Bernardes-Engemann AR; Poester VR; Xavier MO; Meyer W; Zancopé-Oliveira RM; Frases S; Almeida-Paes R Braz J Microbiol; 2024 Jun; 55(2):1359-1368. PubMed ID: 38466550 [TBL] [Abstract][Full Text] [Related]
17. Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility. Mahmoudi S; Zaini F; Kordbacheh P; Safara M; Heidari M Med Mycol; 2016 Aug; 54(6):593-9. PubMed ID: 26933207 [TBL] [Abstract][Full Text] [Related]
18. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance. Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622 [TBL] [Abstract][Full Text] [Related]
19. Potential use of Nikkomycin Z as an anti- Sporothrix spp. drug. Poester VR; Munhoz LS; Larwood D; Martinez M; Stevens DA; Xavier MO Med Mycol; 2021 Apr; 59(4):345-349. PubMed ID: 32634218 [TBL] [Abstract][Full Text] [Related]
20. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]